Canaan Partners vs Frazier Life Sciences
Two firms that co-invest: side by side on stage, sector, check size, and track record, from public filings and the firms' own sites.
| Canaan Partners | Frazier Life Sciences | |
|---|---|---|
| Type | Venture capital | Crossover fund |
| HQ | Stamford | Palo Alto |
| Founded | 1994 | 2015 |
| Check size | $500K – $20M | — |
| Stages | Pre-Seed, Seed, Series A | Seed, Series A, Series B, Series C, Growth, Late Stage |
| Sectors | Biotech, Cloud Computing, Consumer, Deep Tech, Digital Health, E-commerce, Enterprise Software, Fintech, Gaming, Healthtech, Medical Devices | Biotech |
| AUM | $7B | $7B |
| Tracked investments | 380 | 141 |
| Exits (acquired/public) | 4 | 4 |
| Led rounds on record | 1 | — |
| Dated deals, last 24 mo | 15 | 1 |
Shared portfolio · 6
Amicus TherapeuticsChimerix NASDAQ: CMRX www.chimerix.comHalda TherapeuticsOrapharma IncVima Therapeutics, Inc.Cerexa
Frequently asked questions
- Do Canaan Partners and Frazier Life Sciences invest together?
- Yes — Canaan Partners and Frazier Life Sciences appear together in 6 tracked portfolio companies, including Amicus Therapeutics, Chimerix NASDAQ: CMRX www.chimerix.com, Halda Therapeutics, Orapharma Inc, Vima Therapeutics, Inc..